Amneal to Report Third Quarter 2023 Results on November 7, 2023
05 Outubro 2023 - 9:00AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that
the Company will release its third quarter 2023 financial results
on Tuesday, November 7, 2023, prior to market open. The Company
will host a conference call and live webcast with the investment
community at 8:30 a.m. Eastern Time.
The financial results and live webcast will be accessible
through the Investor Relations section of the Company's website at
https://investors.amneal.com.
Individuals may register for the conference call by clicking the
link here. Once registered, participants will receive dial-in
details and unique PIN which will allow them to access the
call.
To access the call through a conference line, dial 1 (833)
470-1428 (in the U.S.) or for a list of toll-free international
numbers, visit this link. The access code for the call is
605508.
A replay of the conference call will be posted shortly after the
call and will be available for seven days.
About Amneal Amneal Pharmaceuticals, Inc. (NYSE: AMRX),
headquartered in Bridgewater, NJ, is a fully integrated global
pharmaceuticals company. We make healthy possible through the
development, manufacturing, and distribution of a diverse portfolio
of approximately 270 pharmaceutical products, primarily within the
United States. In its Generics segment, the Company is expanding
across a broad range of complex product categories and therapeutic
areas, including injectables and biosimilars. In its Specialty
segment, Amneal has a growing portfolio of branded pharmaceuticals
focused primarily on central nervous system and endocrine
disorders, with a pipeline focused on unmet needs. Through its
AvKARE segment, the Company is a distributor of pharmaceuticals and
other products for the U.S. federal government, retail, and
institutional markets. For more information, please visit
www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231005750308/en/
Investor Contact Anthony DiMeo Head of Investor Relations
anthony.dimeo@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024